Latest Euclidean Capital LLC Stock Portfolio

$392Million | No. of Holdings #10

Euclidean Capital LLC Performance

2026 Q1+2.51%

YTD+2.51%

2025+13.33%

About Euclidean Capital LLC and 13F Hedge Fund Stock Holdings

On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Euclidean Capital LLC reported an equity portfolio of $392.3 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of Euclidean Capital LLC are VEU, VB, AMPS. The fund has invested 62.1% of it's portfolio in VANGUARD INTL EQUITY INDEX F and 26% of portfolio in VANGUARD INDEX FDS. <br><br> The fund managers got completely rid off SPDR S&P 500 ETF TR (SPY) and RAPT THERAPEUTICS INC (RAPT) stocks. The fund showed a lot of confidence in some stocks as they added substantially to VANGUARD INTL EQUITY INDEX F (VEU).

Euclidean Capital LLC Equity Portfolio Value

Last Reported on: 15 May, 2026

$392Million

as of May 15, 2026

Euclidean Capital LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Euclidean Capital LLC made a return of 2.51% in the last quarter. In trailing 12 months, it's portfolio return was 18.78%.

Performance
S&P 500

New Buys

No new stocks were added by Euclidean Capital LLC

Additions

Ticker	% Inc.
vanguard intl equity index f	8.47

Additions to existing portfolio by Euclidean Capital LLC

Reductions

None of the existing positions were reduced by Euclidean Capital LLC

Sold off

Ticker	$ Sold
rapt therapeutics inc	-2,785,270
spdr s&p 500 etf tr	-2,798,600

Euclidean Capital LLC got rid off the above stocks

Sector Distribution

Euclidean Capital LLC has about 88.1% of it's holdings in Others sector.

Others
Healthcare
Utilities

Sector	%
Others	88.1
Healthcare	7.5
Utilities	4.4

Market Cap. Distribution

Euclidean Capital LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

UNALLOCATED
SMALL-CAP
MID-CAP
MICRO-CAP

Category	%
UNALLOCATED	88.1
SMALL-CAP	5.1
MID-CAP	4.4
MICRO-CAP	2.4

Stocks belong to which Index?

About 11.3% of the stocks held by Euclidean Capital LLC either belong to S&P 500 or RUSSELL 2000 index.

Others
RUSSELL 2000

Index	%
Others	88.7
RUSSELL 2000	11.3

Top 5 Winners (%)		%
ORIC	oric pharmaceuticals inc	54.9 %
ALEC	alector inc	37.8 %
SRZN	surrozen inc	28.9 %
VB	vanguard index fds	2.7 %
VEU	vanguard intl equity index f	2.0 %

Top 5 Winners ($)		$
VEU	vanguard intl equity index f	4.8 M
ORIC	oric pharmaceuticals inc	4.4 M
VB	vanguard index fds	2.7 M
ALEC	alector inc	0.8 M
SRZN	surrozen inc	0.6 M

Top 5 Losers (%)		%
SRZN	surrozen inc	-20.0 %
AMPS	ishares tr	-13.3 %
FHTX	foghorn therapeutics inc	-11.5 %
TNYA	tenaya therapeutics inc	-2.7 %
PMVP	pmv pharmaceuticals inc	-0.8 %

Top 5 Losers ($)		$
AMPS	ishares tr	-2.7 M
FHTX	foghorn therapeutics inc	-1.0 M
PMVP	pmv pharmaceuticals inc	0.0 M
TNYA	tenaya therapeutics inc	0.0 M
SRZN	surrozen inc	0.0 M

Euclidean Capital LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Euclidean Capital LLC

Euclidean Capital LLC has 10 stocks in it's portfolio. AMPS proved to be the most loss making stock for the portfolio. VEU was the most profitable stock for Euclidean Capital LLC last quarter.

$392.31MTotal Value

12.00Positions

15 May, 2026Last Reported

Current holdings of Current Stock Holdings of Euclidean Capital LLC, last reported on 15 May, 2026. Select a row with a linked ticker to view its historical trend.
Holdingsorted ascending	% Portfolio	Shares Held	$ Value	% Change
ALEC Alector Inc Alector IncALEC Euclidean Capital LLC's holding in Alector Inc over time	0.72%	1,307,860	$2.81M 0.72%	unchanged 0 percentunchanged

AMPS Ishares Tr Ishares TrAMPS Euclidean Capital LLC's holding in Ishares Tr over time	4.41%	369,600	$17.31M 4.41%	unchanged 0 percentunchanged

FHTX Foghorn Therapeutics Inc Foghorn Therapeutics IncFHTX Euclidean Capital LLC's holding in Foghorn Therapeutics Inc over time	1.92%	1,573,760	$7.52M 1.92%	unchanged 0 percentunchanged

ORIC Oric Pharmaceuticals Inc Oric Pharmaceuticals IncORIC Euclidean Capital LLC's holding in Oric Pharmaceuticals Inc over time	3.19%	989,410	$12.54M 3.19%	unchanged 0 percentunchanged

PMVP Pmv Pharmaceuticals Inc Pmv Pharmaceuticals IncPMVP Euclidean Capital LLC's holding in Pmv Pharmaceuticals Inc over time	0.83%	2,627,640	$3.26M 0.83%	unchanged 0 percentunchanged

RAPT Rapt Therapeutics Inc Rapt Therapeutics IncRAPT Euclidean Capital LLC's holding in Rapt Therapeutics Inc over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

SPY Spdr S&P 500 Etf Tr Spdr S&P 500 Etf Tr SPY Euclidean Capital LLC's holding in Spdr S&P 500 Etf Tr over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

SRZN Surrozen Inc Surrozen IncSRZN Euclidean Capital LLC's holding in Surrozen Inc over time	0.65%	87,696	$2.55M 0.65%	unchanged 0 percentunchanged

SRZN Surrozen Inc Surrozen IncSRZN Euclidean Capital LLC's holding in Surrozen Inc over time	0%	170,833	$2.7K 0%	unchanged 0 percentunchanged

TNYA Tenaya Therapeutics Inc Tenaya Therapeutics IncTNYA Euclidean Capital LLC's holding in Tenaya Therapeutics Inc over time	0.18%	1,015,700	$703.3K 0.18%	unchanged 0 percentunchanged

VB Vanguard Index Fds Vanguard Index Fds VB Euclidean Capital LLC's holding in Vanguard Index Fds over time	26.01%	520,000	$102.02M 26.01%	unchanged 0 percentunchanged

VEU Vanguard Intl Equity Index F Vanguard Intl Equity Index F VEU Euclidean Capital LLC's holding in Vanguard Intl Equity Index F over time	62.09%	3,243,480	$243.59M 62.09%	increased 8.47 percentadded